4//SEC Filing
Link David Charles 4
Accession 0001209191-22-060440
CIK 0001833214other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 9:01 AM ET
Size
7.8 KB
Accession
0001209191-22-060440
Insider Transaction Report
Form 4
Link David Charles
Director
Transactions
- Award
Common Stock
2022-12-07$1.21/sh+41,493$49,999→ 57,313 total - Award
Warrant (Common Stock)
2022-12-07+41,493→ 41,493 totalExercise: $1.08From: 2023-06-07Exp: 2027-12-07→ Common Stock (41,493 underlying)
Footnotes (1)
- [F1]On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. David Link in connection with a private placement conducted by the Registrant, pursuant to which Mr. Link purchased (i) an aggregate of 41,493 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 41,493 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889464
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 9:01 AM ET
- Size
- 7.8 KB